Craig Hopkinson
Direttore Tecnico/Scientifico/R&S presso ALKERMES PLC
Patrimonio netto: 3 M $ in data 30/04/2024
Posizioni attive di Craig Hopkinson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALKERMES PLC | Direttore Tecnico/Scientifico/R&S | 30/05/2017 | - |
Storia della carriera di Craig Hopkinson
Precedenti posizioni note di Craig Hopkinson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Direttore/Membro del Consiglio | 01/12/2022 | 02/03/2023 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Direttore Tecnico/Scientifico/R&S | 01/05/2017 | 01/01/2020 |
| VERTEX PHARMACEUTICALS INCORPORATED | Direttore Tecnico/Scientifico/R&S | 01/07/2014 | 01/05/2017 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | 01/01/2013 | 01/07/2014 |
| Presidente | 01/10/2011 | 01/12/2012 |
Formazione di Craig Hopkinson
| University of the Free State | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Irlanda | 2 |
| Sud Africa | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ALKERMES PLC | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Aziende private | 3 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Craig Hopkinson
- Esperienza
